This paradoxical effect has led to difficulties in drug development and more in vivo experiments are needed to investigate the combined effects of Piezo1 on articular cartilage in vivo to better develop therapeutic agents for RA. This evidence concerns the gene PIEZO1 and rheumatoid arthritis.